Literature DB >> 6597564

Pharmacokinetics of beta-lactam antibiotics.

T Bergan.   

Abstract

Beta-lactam antibiotics represent the oldest class of antibiotics used in the treatment of infections. Consequently, a large number of agents have been developed. Penicillins and cephalosporins are generally available for parenteral application. Some are absorbed from the gastrointestinal tract. The serum half-life (t1/2) of most beta-lactams is 1-2 hours. Ceftazidime and temocillin are more long-lasting with a t1/2 of 4-6 hours and ceftriaxone of 8-10 h. These values relate to patients with normal renal function. The elimination is only moderately prolonged for beta-lactams and of little consequences for the dosage regimens, partly because of the high tolerance of this group of antibiotics. Penicillins and cephalosporins are eliminated by glomerular filtration and varying degrees of active transport across the epithelial cells of the renal tubuli and hepatobiliary system. Active transport mechanisms also explain the low concentrations of beta-lactam antibiotics in cerebrospinal fluid. Otherwise, penetration of these agents to unspecialized tissues is good. Substances with a low serum protein binding, such as ampicillin and amoxicillin, reach concentrations in peripheral human lymph which as assessed by the ratios of areas under the concentration curves are 50-80% of the serum levels. The serum protein binding appears to act mainly by inhibiting the rate with which the antibiotic passes into extravascular foci. For instance, temocillin with a serum albumin binding around 85% establishes levels in peripheral lymph which are 50-60% of those in serum. This may be explained by the fact that a higher protein binding is accompanied by more lipid solubility, which are two factors acting in opposite directions as concerns passage by diffusion across body barriers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6597564

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  18 in total

1.  Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses.

Authors:  R H Barbhaiya; S T Forgue; C R Gleason; C A Knupp; K A Pittman; D J Weidler; R R Martin
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Activity of amoxicillin-clavulanate against penicillin-resistant Streptococcus pneumoniae in an experimental respiratory infection model in rats.

Authors:  G M Smith; B Slocombe; K H Abbott; L W Mizen
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Restricted intestinal absorption of some beta-lactam antibiotics by an energy-dependent efflux system in rat intestine.

Authors:  H Saitoh; H Fujisaki; B J Aungst; K Miyazaki
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

5.  Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens.

Authors:  XiangQing Song; MingHui Long
Journal:  Int J Clin Pharm       Date:  2018-08-16

6.  Saturation of the tubular excretion of beta-lactam antibiotics.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

7.  Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors.

Authors:  M Boll; D Markovich; W M Weber; H Korte; H Daniel; H Murer
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

Review 8.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

9.  Transport of beta-lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide/H+ symporter.

Authors:  H Daniel; S A Adibi
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.

Authors:  H H Bräutigam; H Knothe; R Rangoonwala
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.